Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism

Bates, Shannon M.; Ginsberg, Jeffrey S.; Straus, Sharon E.; Rekers, Hans; Sackett, David L.
October 2000
CMAJ: Canadian Medical Association Journal;10/17/2000, Vol. 163 Issue 8, p1016
Academic Journal
AbstractThe identification of conditions associated with an increased risk of venous thromboembolism may indicate the need for aggressive prophylaxis during periods of high risk, prolonged anticoagulant therapy after an initial venous thromboembolic episode, the investigation of asymptomatic family members and the avoidance of oral contraceptives. Advances in laboratory medicine have led to the identification and assessment of many proteins responsible for normal hemostasis, and associations between abnormalities in a number of these proteins and venous thromboembolism have been reported. Without the ability to appraise this information critically, physicians may be unable to determine whether or how they should modify their clinical practice. Criteria for determining whether specific laboratory abnormalities have a relationship with venous thromboembolism are proposed here, and one example of the application of these guidelines is provided.


Related Articles

  • The Clinical Pathologist as Consultant. Marques, Marisa B.; Anastasi, John; Ashwood, Edward; Baron, Beverly; Fitzgerald, Robert; Fung, Mark; Krasowski, Mathew; Laposata, Michael; Nester, Theresa; Rinder, Henry M. // American Journal of Clinical Pathology;Jan2011, Vol. 135 Issue 1, p11 

    This article discusses the role of a clinical pathologist as a consultant. It enumerates the functions of a clinical pathologist: overseeing laboratory testing processes; hands-on patient care; and performing traditional microscopic pathology. It attributes the trend to the need for transfusion...

  • CLOT RETRACTION. Schnell, Zoanne Burgess; Van Leeuwen, Anne M.; Kranpitz, Todd R. // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2003, p320 

    Presents a comprehensive guide to laboratory and diagnostic test for blood clot retraction. Specimen collected and reference value for the test; Discussion on the measurement of blood clot retraction; Role of platelet in the clot retraction process; Information on interfering factors for the...

  • Current Practice in Clinical Thrombosis and Hemostasis. Lambert, Catherine; Hermans, Cedric // Journal of Coagulation Disorders;Oct2011, Vol. 3 Issue 1, p9 

    Clinical thrombosis and hemostasis is emerging as a growing subspecialty area characterized by an increasing interaction between clinical and laboratory medicine and many other disciplines. The impact of these changes on the activity and workload of specialized hemostasis and thrombosis clinics...

  • Thrombophiliescreening 2011: Wer soil wann untersucht werden? Graf, L.; Tsakiris, D. A. // Praxis (16618157);3/28/2012, Vol. 101 Issue 7, p465 

    Heritable thrombophilia as a concept in hemostasis has been continuously discovered parallel to the knowledge on physiology of bleeding disorders. Since the 1980s it has become increasingly popular to search for thrombophilia in patients with thromboembolism and their relatives. Although...

  • COMPLEMENT, TOTAL  // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2006, p411 

    The complement system comprises proteins that become activated and interact in a sequential cascade. The complement system is an important part of the body's natural defense against allergic and immune reactions. It is activated by plasmin and is interrelated with the coagulation and...

  • Tissue factor and coronary artery disease. Moons, Arno H.M.; Levi, Marcel; Peters, Ron J.G. // Cardiovascular Research;Feb2002, Vol. 53 Issue 2, p313 

    Plaque disruption with superimposed thrombosis is the main cause of acute coronary events such as acute myocardial infarction and unstable angina. Among other factors, tissue factor seems to play an important role determining plaque thrombogenicity. Tissue factor is a potent initiator of the...

  • Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden. Otrock, Zaher K.; Taher, Ali T.; Shamseddeen, Wael A.; Zaatari, Ghazi; Bazarbachi, Ali; Mahfouz, Rami A. // Annals of Hematology;Dec2008, Vol. 87 Issue 12, p1013 

    Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), occurs secondary to a number of hereditary and acquired disorders of hemostasis. A recently recognized polymorphism in Factor V (FV) gene H1299R (also named HR2) has been reported to be a possible...

  • TROPONINS I AND T. Schnell, Zoanne Burgess; Van Leeuwen, Anne M.; Kranpitz, Todd R. // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2003, p938 

    Presents a comprehensive guide to laboratory and diagnostic tests for troponins I and T, contractile proteins that regulate the interaction of actin and myosin. Specimen; Indications; Nursing implications and procedure.

  • Genetic control of haemostasis.  // Caribbean Health;Jun2001, Vol. 4 Issue 3, p32 

    The article presents the twin study conducted by the workers in London regarding the use of genetic factors in determining haemostasis in England. The study administered to 502 pairs of female twins to examine the how this factor contribute in the high levels of haemostatic proteins. It also...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics